Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hyder, S. M.
Right arrow Articles by Stancel, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hyder, S. M.
Right arrow Articles by Stancel, G. M.
[Cancer Research 60, 3183-3190, June 15, 2000]
© 2000 American Association for Cancer Research


Endocrinology

Identification of Functional Estrogen Response Elements in the Gene Coding for the Potent Angiogenic Factor Vascular Endothelial Growth Factor1

Salman M. Hyder2, Zafar Nawaz, Constance Chiappetta and George M. Stancel

Department of Integrative Biology and Pharmacology, University of Texas Health Sciences Center, Houston, Texas 77030 [S. M. H., C. C., G. M. S.], and Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030 [Z. N.]

Vascular endothelial growth factor (VEGF) is a potent stimulator of angiogenesis and a prognostic factor for many tumors including those of endocrine-responsive tissues such as the breast and uterus. We and others have previously shown that VEGF is regulated by estradiol and tamoxifen in the uterus and by estradiol in human breast cancer cells, and pharmacological evidence has suggested that this regulation was mediated by transcriptional activation of the estrogen receptor (ER). This prompted us to investigate whether the VEGF gene contains sequences that bind the ER and confer hormonal inducibility to reporter constructs in the presence of the two ER subtypes. These studies identified two sequences homologous to the consensus estrogen response element, GGTCAnnnTGACC, which bind both ER-{alpha} and ER-ß. One of these elements is located in the 5'-untranslated region of the VEGF gene (GGGCAaagTGACT), and the other is located in the 3'-untranslated region (GAGCAcccTGCCC). Competition with excess unlabeled oligonucleotides indicates that these two elements bind both ERs specifically, mutations in either half-site of the two elements abolish receptor binding, and ER-{alpha}- and ER-ß-specific antibodies interact with complexes formed with the corresponding receptor subtypes. In cells containing either ER-{alpha} or ER- ß, the 3'-element behaves as a traditional enhancer that confers hormone inducibility to reporter constructs in an orientation-independent manner, and transcriptional activity is blocked by the pure antiestrogen ICI 182,780. The pattern of transcriptional activity of the element located in the 5'-flanking region is more complex. In the orientation found in the endogenous gene, this element is nonresponsive to ER-ß but confers estrogen-dependent inhibition of transcription with ER-{alpha} that is blunted by ICI 182,780. In the opposite orientation, the 5'-element confers hormone inducibility with either ER-{alpha} or -ß, and ICI 182,780 blocks activation by ER-{alpha} but not by ER-ß. These findings support the hypotheses that estrogens directly regulate VEGF transcription in target tissues and tumors, although such regulation appears likely to involve a complex interplay of cis- and trans-acting elements not previously observed for other hormone-responsive genes.




This article has been cited by other articles:


Home page
EndocrinologyHome page
S. Bake, L. Ma, and F. Sohrabji
Estrogen Receptor-{alpha} Overexpression Suppresses 17{beta}-Estradiol-Mediated Vascular Endothelial Growth Factor Expression and Activation of Survival Kinases
Endocrinology, August 1, 2008; 149(8): 3881 - 3889.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S. van den Driesche, V. M Smith, M. Myers, and W C. Duncan
Expression and regulation of oestrogen receptors in the human corpus luteum
Reproduction, April 1, 2008; 135(4): 509 - 517.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
H. Buteau-Lozano, G. Velasco, M. Cristofari, P. Balaguer, and M. Perrot-Applanat
Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism
J. Endocrinol., February 1, 2008; 196(2): 399 - 412.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
V L Bosquiazzo, J G Ramos, J Varayoud, M Munoz-de-Toro, and E H Luque
Mast cell degranulation in rat uterine cervix during pregnancy correlates with expression of vascular endothelial growth factor mRNA and angiogenesis
Reproduction, May 1, 2007; 133(5): 1045 - 1055.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Bergman Jungestrom, L. U. Thompson, and C. Dabrosin
Flaxseed and Its Lignans Inhibit Estradiol-Induced Growth, Angiogenesis, and Secretion of Vascular Endothelial Growth Factor in Human Breast Cancer Xenografts In vivo
Clin. Cancer Res., February 1, 2007; 13(3): 1061 - 1067.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Hartman, K. Lindberg, A. Morani, J. Inzunza, A. Strom, and J.-A. Gustafsson
Estrogen Receptor {beta} Inhibits Angiogenesis and Growth of T47D Breast Cancer Xenografts
Cancer Res., December 1, 2006; 66(23): 11207 - 11213.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Hamada, M. K. Kim, A. Iwakura, M. Ii, T. Thorne, G. Qin, J. Asai, Y. Tsutsumi, H. Sekiguchi, M. Silver, et al.
Estrogen Receptors {alpha} and {beta} Mediate Contribution of Bone Marrow-Derived Endothelial Progenitor Cells to Functional Recovery After Myocardial Infarction
Circulation, November 21, 2006; 114(21): 2261 - 2270.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
S M Hyder
Sex-steroid regulation of vascular endothelial growth factor in breast cancer.
Endocr. Relat. Cancer, September 1, 2006; 13(3): 667 - 687.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. Bussolino
Small Molecule Approaches for Promoting Ischemic Tissue Vascularization
Circ. Res., August 4, 2006; 99(3): 231 - 233.
[Full Text] [PDF]


Home page
EndocrinologyHome page
K. J. Higgins, S. Liu, M. Abdelrahim, K. Yoon, K. Vanderlaag, W. Porter, R. P. Metz, and S. Safe
Vascular Endothelial Growth Factor Receptor-2 Expression Is Induced by 17{beta}-Estradiol in ZR-75 Breast Cancer Cells by Estrogen Receptor {alpha}/Sp Proteins
Endocrinology, July 1, 2006; 147(7): 3285 - 3295.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
R. C. Bott, R. M. McFee, D. T. Clopton, C. Toombs, and A. S. Cupp
Vascular Endothelial Growth Factor and Kinase Domain Region Receptor Are Involved in Both Seminiferous Cord Formation and Vascular Development During Testis Morphogenesis in the Rat
Biol Reprod, July 1, 2006; 75(1): 56 - 67.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
R. J. Pietras
Biologic Basis of Sequential and Combination Therapies for Hormone-Responsive Breast Cancer
Oncologist, July 1, 2006; 11(7): 704 - 717.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Doi, E. Noiri, A. Nakao, T. Fujita, S. Kobayashi, and K. Tokunaga
Functional Polymorphisms in the Vascular Endothelial Growth Factor Gene Are Associated with Development of End-Stage Renal Disease in Males
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 823 - 830.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Dabrosin
Positive Correlation between Estradiol and Vascular Endothelial Growth Factor but not Fibroblast Growth Factor-2 in Normal Human Breast Tissue In vivo
Clin. Cancer Res., November 15, 2005; 11(22): 8036 - 8041.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
P. A. Wood, K. Bove, S. You, A. Chambers, and W. J.M. Hrushesky
Cancer growth and spread are saltatory and phase-locked to the reproductive cycle through mediators of angiogenesis
Mol. Cancer Ther., July 1, 2005; 4(7): 1065 - 1075.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
R. D. KOOS, A. A. KAZI, M. S. ROBERSON, and J. M. JONES
New Insight into the Transcriptional Regulation of Vascular Endothelial Growth Factor Expression in the Endometrium by Estrogen and Relaxin
Ann. N.Y. Acad. Sci., May 1, 2005; 1041(1): 233 - 247.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
P. L. RYAN, R. C. YOUNGBLOOD, J. HARVILL, and S. T. WILLARD
Photonic Monitoring in Real Time of Vascular Endothelial Growth Factor Receptor 2 Gene Expression under Relaxin-Induced Conditions in a Novel Murine Wound Model
Ann. N.Y. Acad. Sci., May 1, 2005; 1041(1): 398 - 414.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. Soares, G. Balogh, S. Guo, F. Gartner, J. Russo, and F. Schmitt
Evidence for the Notch Signaling Pathway on the Role of Estrogen in Angiogenesis
Mol. Endocrinol., September 1, 2004; 18(9): 2333 - 2343.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. O'Lone, M. C. Frith, E. K. Karlsson, and U. Hansen
Genomic Targets of Nuclear Estrogen Receptors
Mol. Endocrinol., August 1, 2004; 18(8): 1859 - 1875.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M J Currie, V Hanrahan, S P Gunningham, H R Morrin, C Frampton, C Han, B A Robinson, and S B Fox
Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1{alpha}) and the HIF-1{alpha} target gene DEC1, but not lymph node metastasis in primary human breast carcinomas
J. Clin. Pathol., August 1, 2004; 57(8): 829 - 834.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. K. Dey, H. Lim, S. K. Das, J. Reese, B. C. Paria, T. Daikoku, and H. Wang
Molecular Cues to Implantation
Endocr. Rev., June 1, 2004; 25(3): 341 - 373.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Wu, J. Richer, K. B. Horwitz, and S. M. Hyder
Progestin-Dependent Induction of Vascular Endothelial Growth Factor in Human Breast Cancer Cells: Preferential Regulation by Progesterone Receptor B
Cancer Res., March 15, 2004; 64(6): 2238 - 2244.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Garvin and C. Dabrosin
Tamoxifen Inhibits Secretion of Vascular Endothelial Growth Factor in Breast Cancer in Vivo
Cancer Res., December 15, 2003; 63(24): 8742 - 8748.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
K. C. Fertuck, J. E. Eckel, C. Gennings, and T. R. Zacharewski
Identification of temporal patterns of gene expression in the uteri of immature, ovariectomized mice following exposure to ethynylestradiol
Physiol Genomics, October 17, 2003; 15(2): 127 - 141.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
H. E. Turner, A. L. Harris, S. Melmed, and J. A. H. Wass
Angiogenesis in Endocrine Tumors
Endocr. Rev., October 1, 2003; 24(5): 600 - 632.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D. Gagne, M. Page, G. Robitaille, P. Hugo, and D. Gosselin
Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis
Hum. Reprod., August 1, 2003; 18(8): 1674 - 1680.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Guo, Q. Fang, H.-Q. Tao, C. A. Schafer, B. M. Fenton, I. Ding, B. Hu, and S.-Y. Cheng
Overexpression of Vascular Endothelial Growth Factor by MCF-7 Breast Cancer Cells Promotes Estrogen-independent Tumor Growth in Vivo
Cancer Res., August 1, 2003; 63(15): 4684 - 4691.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. E. Murphy, M. R. J. Lansdown, V. Speirs, and P. J. Carder
Correspondence re: K. Heer et al., Serum Vascular Endothelial Growth Factor in Breast Cancer: Its Relation with Cancer Type and Estrogen Receptor Status. Clin. Cancer Res., 7: 3491-3494, 2001.
Clin. Cancer Res., August 1, 2003; 9(9): 3514 - 3514.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Heer
Reply
Clin. Cancer Res., August 1, 2003; 9(9): 3515 - 3515.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Dabrosin
Variability of Vascular Endothelial Growth Factor in Normal Human Breast Tissue in Vivo during the Menstrual Cycle
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2695 - 2698.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
D. R. Danforth, L. K. Arbogast, S. Ghosh, A. Dickerman, R. Rofagha, and C. I. Friedman
Vascular Endothelial Growth Factor Stimulates Preantral Follicle Growth in the Rat Ovary
Biol Reprod, May 1, 2003; 68(5): 1736 - 1741.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. M. J. J. Berns, J. G. M. Klijn, M. P. Look, N. Grebenchtchikov, R. Vossen, H. Peters, A. Geurts-Moespot, H. Portengen, I. L. van Staveren, M. E. Meijer-van Gelder, et al.
Combined Vascular Endothelial Growth Factor and TP53 Status Predicts Poor Response to Tamoxifen Therapy in Estrogen Receptor-positive Advanced Breast Cancer
Clin. Cancer Res., April 1, 2003; 9(4): 1253 - 1258.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Stevens, J. Soden, P. E. Brenchley, S. Ralph, and D. W. Ray
Haplotype Analysis of the Polymorphic Human Vascular Endothelial Growth Factor Gene Promoter
Cancer Res., February 15, 2003; 63(4): 812 - 816.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Buteau-Lozano, M. Ancelin, B. Lardeux, J. Milanini, and M. Perrot-Applanat
Transcriptional Regulation of Vascular Endothelial Growth Factor by Estradiol and Tamoxifen in Breast Cancer Cells: A Complex Interplay between Estrogen Receptors {alpha} and {beta}
Cancer Res., September 1, 2002; 62(17): 4977 - 4984.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
D. Cracchiolo, J. W. Swick, L. McKiernan, E. Sloan, S. Raina, C. Sloan, and D. L. Wendell
Estrogen-Dependent Growth of a Rat Pituitary Tumor Involves, But Does Not Require, a High Level of Vascular Endothelial Growth Factor
Experimental Biology and Medicine, July 1, 2002; 227(7): 492 - 499.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. M. Hyder
The Role of Steroid Hormones on the Regulation of Vascular Endothelial Growth Factorm
Am. J. Pathol., July 1, 2002; 161(1): 345 - 346.
[Full Text] [PDF]


Home page
Cancer Res.Home page
L. Bogin and H. Degani
Hormonal Regulation of VEGF in Orthotopic MCF7 Human Breast Cancer
Cancer Res., April 1, 2002; 62(7): 1948 - 1951.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
R. N. TAYLOR, D. I. LEBOVIC, and M. D. MUELLER
Angiogenic Factors in Endometriosis
Ann. N.Y. Acad. Sci., March 1, 2002; 955(1): 89 - 100.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
F. TOSETTI, N. FERRARI, S. DE FLORA, and A. ALBINI
Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents
FASEB J, January 1, 2002; 16(1): 2 - 14.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. Soares, J. S. Reis-Filho, F. Gartner, F. C. Schmitt, L. Iruela-Arispa, and M. D. Graubert
Vascular Endothelial Growth Factor, Transforming Growth Factor-{alpha}, and Estrogen Receptors: Possible Cross-Talks and Interactions
Am. J. Pathol., January 1, 2002; 160(1): 381 - 383.
[Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
C. J. FABIAN and B. F. KIMLER
Beyond Tamoxifen: New Endpoints for Breast Cancer Chemoprevention, New Drugs for Breast Cancer Prevention
Ann. N.Y. Acad. Sci., December 1, 2001; 952(1): 44 - 59.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L.-J. Chew, X. Yuan, S. E. Scherer, L. Qie, F. Huang, W. P. Hayes, and V. Gallo
Characterization of the Rat GRIK5 Kainate Receptor Subunit Gene Promoter and Its Intragenic Regions Involved in Neural Cell Specificity
J. Biol. Chem., November 2, 2001; 276(45): 42162 - 42171.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
R. N. TAYLOR, D. I. LEBOVIC, D. HORNUNG, and M. D. MUELLER
Endocrine and Paracrine Regulation of Endometrial Angiogenesis
Ann. N.Y. Acad. Sci., September 1, 2001; 943(1): 109 - 121.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C. M. Klinge
Estrogen receptor interaction with estrogen response elements
Nucleic Acids Res., July 15, 2001; 29(14): 2905 - 2919.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. A. Foekens, H. A. Peters, N. Grebenchtchikov, M. P. Look, M. E. Meijer-van Gelder, A. Geurts-Moespot, T. H. van der Kwast, C. G. J. Sweep, and J. G. M. Klijn
High Tumor Levels of Vascular Endothelial Growth Factor Predict Poor Response to Systemic Therapy in Advanced Breast Cancer
Cancer Res., July 1, 2001; 61(14): 5407 - 5414.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H. Cardenas, K.A. Burke, R.M. Bigsby, W.F. Pope, and K.P. Nephew
Estrogen Receptor {beta} in the Sheep Ovary During the Estrous Cycle and Early Pregnancy
Biol Reprod, July 1, 2001; 65(1): 128 - 134.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. A. Mills
Changing colors in mice: an inducible system that delivers
Genes & Dev., June 15, 2001; 15(12): 1461 - 1467.
[Full Text] [PDF]


Home page
BloodHome page
E. Morii, H. Ogihara, K. Oboki, C. Sawa, T. Sakuma, S. Nomura, J. D. Esko, H. Handa, and Y. Kitamura
Inhibitory effect of the mi transcription factor encoded by the mutant mi allele on GA binding protein-mediated transcript expression in mouse mast cells
Blood, May 15, 2001; 97(10): 3032 - 3039.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. Bos, H. Zhong, C. F. Hanrahan, E. C. M. Mommers, G. L. Semenza, H. M. Pinedo, M. D. Abeloff, J. W. Simons, P. J. van Diest, and E. van der Wall
Levels of Hypoxia-Inducible Factor-1{{alpha}} During Breast Carcinogenesis
J Natl Cancer Inst, February 21, 2001; 93(4): 309 - 314.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. L. Blackwell, Z. A. Haroon, S. Shan, W. Saito, G. Broadwater, C. S. Greenberg, and M. W. Dewhirst
Tamoxifen Inhibits Angiogenesis in Estrogen Receptor-negative Animal Models
Clin. Cancer Res., November 1, 2000; 6(11): 4359 - 4364.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.